105 related articles for article (PubMed ID: 3039119)
1. Neurokinin-induced salivation in the anesthetized rat: a three receptor hypothesis.
Murray CW; Cowan A; Wright DL; Vaught JL; Jacoby HI
J Pharmacol Exp Ther; 1987 Aug; 242(2):500-6. PubMed ID: 3039119
[TBL] [Abstract][Full Text] [Related]
2. Neurokinins induce a relaxation of the rat duodenum "in vivo" by activating postganglionic sympathetic elements in prevertebral ganglia: involvement of an NK-2 type of neurokinin receptor.
Giuliani S; Maggi CA; Rovero P; Meli A
J Pharmacol Exp Ther; 1988 Jul; 246(1):322-7. PubMed ID: 2455794
[TBL] [Abstract][Full Text] [Related]
3. Motor effect of neurokinins on the rat duodenum: evidence for the involvement of substance K and substance P receptors.
Maggi CA; Giuliani S; Manzini S; Santicioli P; Meli A
J Pharmacol Exp Ther; 1986 Jul; 238(1):341-51. PubMed ID: 2425078
[TBL] [Abstract][Full Text] [Related]
4. Studies on tachykinin (neurokinin) receptor coupled with inositol phospholipid hydrolysis and salivation in rat salivary glands.
Wei JW; Lee FC
Chin J Physiol; 1992; 35(4):291-301. PubMed ID: 1285003
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of multiple neurokinin receptors in the guinea pig ileum.
Jacoby HI; Lopez I; Wright D; Vaught JL
Life Sci; 1986 Nov; 39(21):1995-2003. PubMed ID: 2431245
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
7. NK-1 receptors mediate the tachykinin stimulation of salivary secretion: selective agonists provide further evidence.
Giuliani S; Maggi CA; Regoli D; Drapeau G; Rovero P; Meli A
Eur J Pharmacol; 1988 Jun; 150(3):377-9. PubMed ID: 2458268
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
Helke CJ; Phillips ET; O'Neill JT
J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation.
Takeda Y; Krause JE
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):392-6. PubMed ID: 2463627
[TBL] [Abstract][Full Text] [Related]
10. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
[TBL] [Abstract][Full Text] [Related]
11. Activation of substance P receptors leads to membrane potential responses in cultured astrocytes.
Wienrich M; Kettenmann H
Glia; 1989; 2(3):155-60. PubMed ID: 2473032
[TBL] [Abstract][Full Text] [Related]
12. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
13. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
14. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor.
Whitehead TL; McNair SD; Hadden CE; Young JK; Hicks RP
J Med Chem; 1998 Apr; 41(9):1497-506. PubMed ID: 9554882
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin A-(4-10): a potent bronchospastic agent virtually devoid of sialologic properties in anaesthetized guinea-pigs.
Manzini S; Conti S; Maggi CA; Rovero P; Ballati L
Eur J Pharmacol; 1988 Apr; 148(3):475-8. PubMed ID: 2454832
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
17. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
Piedimonte G; Bertrand C; Geppetti P; Snider RM; Desai MC; Nadel JA
J Pharmacol Exp Ther; 1993 Jul; 266(1):270-3. PubMed ID: 7687291
[TBL] [Abstract][Full Text] [Related]
18. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
20. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
Lecci A; Giuliani S; Patacchini R; Maggi CA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1327-32. PubMed ID: 8383746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
